Centro de Documentacion de Fundación MAPFRE - Risk-benefit assessments of human diseases: optimum dose for intervention

MAP20071506676

Risk-benefit assessments of human diseases: optimum dose for intervention / David W. Gaylor

A simple procedure is proposed in order to quantify the tradeoff between a loss suffered from an illness due to exposure to a microbial pathogen and a loss due to a toxic effect, perhaps a different illness, induced by a disinfectant employed to reduce the microbial exposure. Estimates of these two types of risk as a function of disinfectant dose and their associated relative losses provide information for the estimation of the optimum dose of disinfectant that minimizes the local expected loss

En: Risk analysis : an international journal. - New York and London. - Vol. 25, nº 1, February 2005 ; p. 161-168

1. Higiene industrial . 2. Desinfectantes . 3. Enfermedades . 4. Sustancias tóxicas y peligrosas . 5. Minerales . 6. Microbiología . 7. Análisis de riesgos . 8. Modelos matemáticos . I. Título. II. Título: Risk analysis : an international journal.